Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Joaquin Duato
Pharma
How J&J CEO broke a stalemate and won Intra-Cellular in M&A push
J&J’s proposed $14.6 billion purchase of Intra-Cellular Therapies was made possible by a key intervention from J&J’s CEO Joaquin Duato, a filing shows.
Angus Liu
Feb 7, 2025 11:24am
J&J upholds sales growth confidence as Stelara biosims file in
Jan 22, 2025 11:26am
The top 10 best-paid CEOs in Big Pharma in 2023
Jun 17, 2024 3:00am
J&J hit with talc-related class action lawsuit in New Jersey
May 23, 2024 10:46am
J&J CEO Joaquin Duato receives major pay raise to $28.4M in 2023
Mar 13, 2024 11:45am
CEOs from BMS, J&J and Merck defend high drug costs to senators
Feb 8, 2024 3:05pm